Trial · NCT02779764
Registered outcomes28
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 28
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Hemoglobin (Hb) Response Rate from Week 18 to Week 24 | Week 18 to 24 | Hb response defined as average Hb within the target range |
| Secondary | Hb Response Rate from Week 46 to Week 52 | Week 46 to 52 | |
| Secondary | Average Hb from Week 18 to Week 24 | Week 18 to Week 24 | |
| Secondary | Average Hb from Week 46 to Week 52 | Week 46 to Week 52 | |
| Secondary | Change from baseline in the average Hb from Week 18 to Week 24 | Baseline and Weeks 18 to 24 | |
| Secondary | Change from baseline in the average Hb from Week 46 to Week 52 | Baseline and Weeks 46 to 52 | |
| Secondary | Proportion of participants with Hb values within the target value in each post-dosing time point | Up to Week 52 | |
| Secondary | Change from baseline in Hb to each post-dosing time point | Baseline and Up to Week 52 | |
| Secondary | Proportion of measurement points with target Hb level from Week 18 to Week 24 | Week 18 to Week 24 | |
| Secondary | Proportion of measurement points with target Hb level from Week 46 to Week 52 | Week 46 to Week 52 | |
| Secondary | Rate of rise in Hb levels (g/dL/week) from week 0 to at the earliest date of week 4, time of discontinuation, or time of dose adjustment | Up to Week 4 | |
| Secondary | Average hematocrit level | Up to Week 52 | |
| Secondary | Average reticulocyte level | Up to Week 52 | |
| Secondary | Average Fe level | Up to Week 52 | |
| Secondary | Average ferritin level | Up to Week 52 | |
| Secondary | Average transferrin level | Up to Week 52 | |
| Secondary | Average total iron binding capacity level | Up to Week 52 | |
| Secondary | Average soluble transferrin receptor level | Up to Week 52 | |
| Secondary | Average transferrin saturation level | Up to Week 52 | |
| Secondary | Average reticulocyte hemoglobin content level | Up to Week 52 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02779764/registered